A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice

CompletedOBSERVATIONAL
Enrollment

184

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

January 27, 2021

Study Completion Date

January 27, 2021

Conditions
Plaque Psoriasis
Interventions
DRUG

Apremilast

Apremilast is prescribed in accordance with the terms of the SmPC and the marketing authorizations.

Trial Locations (16)

25123

UOC Dermatologia ASST Spedali Civili, Brescia

28100

Dermatologia A.O.U. Maggiore della Carità, Novara

44124

UOC Dermatologia Arcispedale Sant'Anna, Cona

50025

Dermatologia Ospedale Piero Palagi, Florence

60126

SOD Clinica Dermatologica A.O.U. Riuniti Umberto I Lancisi Salesi, Ancona

70124

Dermatologica e Venereologia Univ. A.O.U. Consorziale Policlinico, Bari

80131

Dermatologia A.O.U. Federico II, Napoli

80138

UOC Clinica Dermatologica A.O.U. Università della Campania Vanvitelli, Napoli

90127

UOC Dermatologia e MST A.O.U. Policlinico P. Giaccone, Palermo

95100

Dermatologia A.O.U. Policlinico-Vittorio Emanuele PO S.Marco, Catania

98125

UOC Dermatologia A.O.U. Policlinico G. Martino, Messina

98158

Dermatologia Azienda Ospedaliera Papardo, Messina

09123

UOS Clinica Dermatologica Ospedale San Giovanni di Dio, Cagliari

00133

Clinica Dermatologica Policlinico Tor Vergata, Roma

00161

Dermatologia e Venereologia A.O.U. Policlinico Umberto I, Roma

04019

UOC Dermatologia Universitaria Ospedale A. Fiorini, Terracina

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY